Manager Development
Resume:
Keld Sorensen
Leander, TX *****
512-***-**** . ************@*****.***
Summary of Qualifications
A highly experienced, technically competent director of R&D and business
development, with expertise in the areas of molecular biology, proteomics,
cell culture as well as diagnostics. A proven track record of external
business development, technology assessment, technology development,
product design, execution, team management and negotiations. High level of
fiscal knowledge and ability to operate in a manner generating high ROI on
R&D investments. Ability to create positive, energetic and passionate
teams. Expertise in IP analysis and technology assessment.
Business development expertise
Expertise in technology assessment (internal and external)
Strong project management skills, both local and outsourced
Experienced IP and FTO analyst and writer
Track record of product development in molecular biology, proteomics, cell
culture and diagnostics
Strong analytical skills, including data analysis
Excellent business acumen
Science Advisory Board experience
Team leadership and people management expertise
Education
Ph.D. in Biochemistry
1 University of Copenhagen, Denmark
2 MS in Organic Chemistry
University of Copenhagen, Denmark
3
4 Formal Postdoctoral training:
University of Bern, Switzerland, 2 years
Texas A&M University, 1 year
US Patents Issued
4,892,405 & 5,266,686 & 5,535,858 / Several additional patents filed and
pending.
Professional Experience
1
2005-2011 Luminex / Bioscience Group - Austin, Texas
2 Executive Director of R&D, Bioscience Group and Assay Advanced Technology
Group.
Established an R&D function within the company to create an additional
business unit for the purpose of selling reagents and kits, based on the
xMAP multiplexing technology platform.
Established in-house teams, and outsourcing for R&D, with project
management
Established new technology team in addition to development team for
technology assessment
Developed IVD and RUO kits for sale within first year of employment (FDA)
Lead in the Technology Assessment Board for Luminex and Luminex Molecular
Dx
Lead in the Patent Committee for Luminex
Conducted high level negotiations with external and internal technology
partners.
Established scientific exchanges with external partners
Created and managed budget for R&D function - internal and external
Established invention review process, IP review, and FTO review procedures
Conducted extensive technology analysis and review of "in licensed"
technologies
Traveled extensively for purposes of managing partnerships and external
projects
Implemented ELN (Electronic Lab Notebook system)
3 1998-2005 Sigma-Aldrich / Life Sciences Division - St. Louis, MO
1 Director of R&D
Directed a group of R&D Managers and the overall Sigma-Aldrich research
effort in all areas, with main focus on molecular biology, cell culture and
proteomics. Managed six direct reports, each with variable number of
direct reports for a total of 80+ scientists. Direct fiscal and budget
responsibilities for entire team. Direct involvement with establishing and
acquiring technology from inside and outside sources.
Conducted due-diligence reviews of acquisition targets, including IP
reviews with IP attorneys.
Several patents issued to R&D scientists under my direct and indirect
supervision.
Planned and directed expansion of R&D, including hiring of researchers and
managers - groups size increased from 10 FTEs to over 100 FTEs in a span
of 7 years.
Established new research programs that resulted in a number of successful
product lines, both for manual and highly automated systems (High
Throughput Screening), micro-arrays, qPCR and more.
Established internal training programs for R&D and Technical Services
enhancing customer satisfaction.
Enhanced utilization of various R&D sites in the company (Israel, Boston,
Switzerland etc).
Part of business analysis team to ensure optimal R&D coverage, including
decisions to grow in certain areas and reduce in others.
Established online access for all scientists in the company to important
scientific journals, with full fiscal and operation responsibility.
1997-1998 Sigma Aldrich, St. Louis, MO
Manager R&D
Managed a R&D group. Planned and supervised R&D development of new
Molecular Biology Products. Met development deadlines in a team setting,
including marketing, sales, Technical Services and other teams. Oversaw
successful development of families of products. Promoted to Director of
R&D with responsibilities to further grow the R&D teams.
4 1991-1997 Pierce Chemical Company - Rockford, Illinois
1 Senior Research Scientist
Head of laboratory team designed to quickly implement technologies that do
not originate with Pierce Chemical (Rapid Response Team). In addition,
performed basic research in the field of immunochemistry, biochemistry and
molecular biology, to be incorporated in to new products. High level of
collaboration with other researchers.
Acted as facilitator for various internal groups and functions.
Implementation of "instruction booklets on demand."
Temporary Manager of Technical Assistance Department. Pierce Chemical Co
(6 months)
R&D lead for ISO implementation
Patented and non-patented products that generated 10% of corporate income
5 1987-1991 NTD Laboratories - Carle Place, New York
1 Laboratory Director
Performed research and development of human and veterinary specific
diagnostic testing, mainly ELISA. Contacted and collaborated with
researchers at universities and clinical researchers. Ran the day-to-day
operation of veterinary testing laboratory, including documentation and
business development. Invented screening methods for pre-natal screening.
1983-1987 University of Bern, Switzerland
Research Scientist
Developed research programs on neuronal proteins, including monoclonal
antibody development, assay development and diagnostic development.
Scientific Community Collaborations
2010
Presentor at the Newborn Screening in the genomics age a conference by
invitation only at the NIH to set R&D directions for grants in the newborn
screening arena.
2008 - 2010
Teaching at EMBL and other academic institutions on miRNA assays and their
usage for cancer research.
2006-2011
Board member of Advisory Committee for "New technologies in newborn
screening". Chaired by Dr Nancy Green, March of Dimes and Columbia
University Medical School.
2006-2007
Chair for program "miRNA assay tools" at the Molecular Medicine Tri-
Conference. Responsible for planning, sign-up and scheduling of speakers.
2000 - 2004
Sloan Industrial Advisor to Professional MS program, Michigan State
University, E. Lansing MI.
1996-1997
Co-Chair for program - "Microplate 1997" international conference
Responsible for planning and scheduling of part of the conference,
including assignment of speakers, design of speakers instructions and sign-
up of speakers.
1993-1997
Adjunct Assistant Professor of Biochemistry and Immunology. University of
Illinois, College of Medicine.
Responsible for Research and teaching. Position in parallel to main job.
1994-1995
Member, International Advisory Board. 11th International symposium on
affinity chromatography and biological recognition. Chairman: William H.
Scouten, Biotechnology Center, Utah State University.
Contact this candidate